References
- Hricik D E, Browning P J, Kopelman R, Goorno W E, Madias N E, Dzau V J. Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 1983; 308: 373–376
- Shionoiri H, Uneda S, Tochikubo O, Ohnishi T, Harada J, Sesoko S, Goto E, Fujishima S, Kaneko Y. Effects of angiotensin converting enzyme inhibitor SQ 14225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension. Jan J Nephrol 1980; 22: 13–22
- Hollenberg N K, Meggs L G, Williams G H, Katz J, Garnic J D, Harrington D P. Sodium intake and renal response to captopril in normal man and in essential hypertension. Kidney Int 1981; 20: 240–245
- Vaughan E D, Carey R M, Ayers C R, Peach M. Haemodialysis J.-resistant hypertension: Control with an orally-active inhibitor of converting enzyme. J Clin Endocrinol Metab 1977; 48: 869–873
- Brunner H R, Waeber B, Wauters J P, Turini G, McKinsky D, Gavras H. Inappropriate renin secretion unmasked by captopril (SQ 14225) in hypertension of chronic renal failure. Lancet 1978; II: 704–707
- Franklin S S, Smith R D. Comparison of effects of enalapril plus hydrochlorothiazide versus standard tripple therapy on renal function in renovascular hypertension. Am J Med 1985; 79(3C)14–23
- Hall J E, Guyton A C, Smith M J, Jr, Coleman T G. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol 1980; 239: F271–F280